Stock listing
ALT Stock Price, News, Filings & Events — Altimmune, Inc.
Selected listing: ALT · NASDAQ · USD · US
This page tracks Altimmune, Inc.'s ALT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALT:NASDAQ. ALT:NASDAQ is the stock-level entry point for investors researching Altimmune, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Altimmune, Inc. is a public company traded under the ticker ALT in the American market. The company has a market capitalization of approximately $538.7 million. Altimmune focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- ALT:NASDAQ
- Asset type
- Stock
- Market cap
- $605.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Altimmune, Inc. ALT:NASDAQ stock context
This page tracks Altimmune, Inc.'s ALT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALT:NASDAQ. ALT:NASDAQ is the stock-level entry point for investors researching Altimmune, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Altimmune, Inc. is a public company traded under the ticker ALT in the American market. The company has a market capitalization of approximately $538.7 million. Altimmune focuses on developing innovative therapies to address unmet medical needs.
Latest news from Altimmune, Inc.
Altimmune Announces Second Quarter 2026 Financial Results and Business Update
August 12, 2026
Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
August 5, 2026
Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH
August 3, 2026
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
July 30, 2026
Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder
July 28, 2026
Altimmune, Inc. earnings calls
Altimmune, Inc. (ALT) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Altimmune, Inc.
Altimmune, Inc. investor report
Review AI stock analysis and investor report context for ALT:NASDAQ.
Altimmune, Inc. company profile
View the public company page for Altimmune, Inc. on 6ix.
Altimmune, Inc. news
Read company news and market updates connected to Altimmune, Inc..
Altimmune, Inc. investor events
Find investor webinars, events, and replay context for Altimmune, Inc..
Alternate listings
3G0:GETTEX
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
A2N5Z6:LS
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
A2N5Z6:LSX
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
ALT1:BMV
MX · MXN
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
ALT1:BIVA
MX · MXN
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
3G0:TRADEGATE
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
ALT:BOATS
US · USD
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
0A4C:LSE
GB · USD
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
3G0:DUS
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
3G0:FWB
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
3G0:HAM
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.
3G0:MUN
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is ALT:NASDAQ.